Whether they can have children is one of the major concerns for adult survivors of childhood and adolescent cancer because cancer treatment may compromise fertility. For cancer survivors who can have children, two new Hutchinson Center studies may help alleviate fears that their childhood disease will adversely impact their newborns.
The studies, which were presented as companion papers in the journal Archives of Pediatrics & Adolescent Medicine, found:
“The take-home message overall is positive. If you had cancer as a younger person and you are able to have children then most likely your children will be fine,” said Dr. Eric Chow, corresponding author and research associate in the Clinical Research and Public Health Sciences divisions. “Most of the other side effects that people have the most concern about—birth defects and more serious maternal complications during pregnancy—we didn’t find those things.”
Chow said pregnant women who had cancer in childhood should seek prenatal care early in their pregnancies and make sure their physicians and obstetricians know about their cancer history. Close monitoring may help prevent early births and underweight newborns.
A possible explanation for the increased rates of preterm delivery and underweight newborns found among female cancer survivors is that some cancer treatments may affect the growth of and blood flow to the uterus during pregnancy, said Chow, who is a pediatric oncologist. Previous studies have shown that radiation therapy to the uterus can increase the chances of subsequent preterm labor and low birth weight.
For the two papers, Chow and the principal investigator Dr. Beth Mueller, a cancer and reproductive health epidemiologist in PHS, used data from cancer registries operated by the National Institutes of Health in four U.S. regions—Seattle, Detroit, Salt Lake City and Atlanta. They identified boys and girls who were diagnosed with cancer before the age of 20 between 1973 and 2000. Linked birth records from the four regions identified the first live births to these survivors after diagnosis. They identified a total of 1,898 offspring of female cancer survivors and compared their outcomes to 14,278 controls selected from birth records. The study identified 470 offspring of male cancer survivors and compared them to 4,150 controls.
The National Cancer Institute funded the studies through its Surveillance, Epidemiology, and End Results (SEER) program. Co-authors of the papers included researchers from the University of Washington, Huntsman Cancer Institute in Salt Lake City, Wayne State University in Detroit, and Emory University in Atlanta.